Hepatitis b drug breakthrough: could you finally stop treatment?

NCT ID NCT04782375

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 29 times

Summary

This study looks at whether adults with chronic hepatitis B who have been on antiviral drugs for at least 2 years and have no liver scarring can safely stop taking them. The 140 participants will be monitored for virus return and liver problems. The goal is to see if stopping treatment is safe and effective for carefully selected patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS B, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

  • Chung-Ang University Hospital

    Seoul, South Korea

  • Konkuk University Hospital

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Kyung-Hee University Hospital

    Seoul, South Korea

  • Kyungpook National University Hospital

    Daegu, South Korea

  • Samsung Medical center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Ulsan University Hospital

    Ulsan, South Korea

Conditions

Explore the condition pages connected to this study.